TOWA Pharmaceutical Co (FRA:6QC) Inventories, Finished Goods: €296 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6QC TOWA Pharmaceutical Co Ltd FRA:6QC
89 GF Score
Price €21.60
GF Value €18.22
Valuation Modestly Overvalued
! 10 Warning Signs
View Full Analysis

What is TOWA Pharmaceutical Co Inventories, Finished Goods?

TOWA Pharmaceutical Co FRA:6QC 89 Inventories, Finished Goods is €296 Mil as of Mar. 2026. GuruFocus rates FRA:6QC with a GF Score™ of 89/100 and a GF Value™ of €18.22 (Modestly Overvalued). The stock has 10 warning signs investors should review.

TOWA Pharmaceutical Co's quarterly finished goods declined from Sep. 2025 (€292 Mil) to Dec. 2025 (€275 Mil) but then increased from Dec. 2025 (€275 Mil) to Mar. 2026 (€296 Mil).

TOWA Pharmaceutical Co's annual finished goods declined from Mar. 2024 (€301 Mil) to Mar. 2025 (€278 Mil) but then increased from Mar. 2025 (€278 Mil) to Mar. 2026 (€296 Mil).

TOWA Pharmaceutical Co Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for TOWA Pharmaceutical Co's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TOWA Pharmaceutical Co Inventories, Finished Goods Chart

TOWA Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 245.79 310.65 300.81 277.83 295.75

TOWA Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 277.83 273.51 292.22 274.72 295.75
FRA:6QC
89GF Score
TOWA Pharmaceutical Co Ltd FRA:6QC
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TOWA Pharmaceutical Co Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of €296 Mil mean?
TOWA Pharmaceutical Co (FRA:6QC) has a Inventories, Finished Goods of €296 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on TOWA Pharmaceutical Co and its competitors.
Is TOWA Pharmaceutical Co's Inventories, Finished Goods too high?
TOWA Pharmaceutical Co's current Inventories, Finished Goods is €296 Mil. Overall, TOWA Pharmaceutical Co has a GF Score™ of 89/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TOWA Pharmaceutical Co's Inventories, Finished Goods compare to ZTS?
TOWA Pharmaceutical Co's Inventories, Finished Goods of €296 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on TOWA Pharmaceutical Co and its competitors. TOWA Pharmaceutical Co's current Inventories, Finished Goods is €296 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TOWA Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, TOWA Pharmaceutical Co (FRA:6QC) is currently considered Modestly Overvalued. The stock's GF Value™ is €18.22, compared to a current price of €21.60 — trading 18.6% above its estimated fair value. The current Inventories, Finished Goods is €296 Mil. TOWA Pharmaceutical Co's overall GF Score™ is 89/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For TOWA Pharmaceutical Co (FRA:6QC), the current Inventories, Finished Goods is €296 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TOWA Pharmaceutical Co (FRA:6QC) Overvalued in 2026?

Based on GuruFocus' analysis, TOWA Pharmaceutical Co stock appears to be overvalued. The current stock price of €21.60 is trading 18.6% above its estimated GF Value™ of €18.22. GuruFocus considers TOWA Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for FRA:6QC:

  • Inventories, Finished Goods: €296 Mil
  • GF Value™: €18.22 vs. price of €21.60 (18.6% above fair value)
  • GF Score™: 89/100 with 10 warning signs

No single metric tells the full story. See the FRA:6QC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TOWA Pharmaceutical Co Business Description

Other Exchanges 4553:Japan
Address 2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
89GF Score

Get the complete analysis for FRA:6QC

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.60
Price
€18.22
GF Value